Abstract | BACKGROUND: METHODOLOGY AND PRINCIPAL FINDINGS: The allergen-driven asthma phenotype was significantly reduced in sPLA2-V-deficient mice but to a lesser extent than observed previously in sPLA2-X-deficient mice. The most striking difference observed between the sPLA2-V and sPLA2-X knockouts was the significant impairment of the primary immune response to the allergen ovalbumin (OVA) in the sPLA2-V(-/-) mice. The impairment in eicosanoid generation and dendritic cell activation in sPLA2-V(-/-) mice diminishes Th2 cytokine responses in the airways. CONCLUSIONS: This paper illustrates the diverse roles of sPLA2s in the immunopathogenesis of the asthma phenotype and directs attention to developing specific inhibitors of sPLA2-V as a potential new therapy to treat asthma and other allergic disorders.
|
Authors | William R Henderson Jr, Xin Ye, Ying Lai, Zhanglin Ni, James G Bollinger, Ying-Tzang Tien, Emil Y Chi, Michael H Gelb |
Journal | PloS one
(PLoS One)
Vol. 8
Issue 2
Pg. e56172
( 2013)
ISSN: 1932-6203 [Electronic] United States |
PMID | 23451035
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Ovalbumin
- Group V Phospholipases A2
- Group X Phospholipases A2
|
Topics |
- Animals
- Asthma
(enzymology, genetics, immunology)
- CD4-Positive T-Lymphocytes
(metabolism)
- Disease Models, Animal
- Group V Phospholipases A2
(genetics, metabolism)
- Group X Phospholipases A2
(genetics, metabolism)
- Immunohistochemistry
- Mice
- Mice, Knockout
- Ovalbumin
(immunology)
- Polymerase Chain Reaction
- Th2 Cells
(metabolism)
|